<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02798016</url>
  </required_header>
  <id_info>
    <org_study_id>UDMS-Dermat-01-2016</org_study_id>
    <nct_id>NCT02798016</nct_id>
  </id_info>
  <brief_title>Treatment of Atrophic Acne Scars With Platelet-Rich Plasma and Skin Needling</brief_title>
  <official_title>Treatment of Atrophic Acne Scars With Platelet-Rich Plasma Alone or in Combination With Skin Needling: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will collect blood specimens from the participating patients and then blood
      samples will be centrifuged in order to collect platelet-rich plasma which is going to be
      injected in the atrophic acne scars. A split-face design is going to used in this randomized
      controlled trial. In the control side of the face, micro-needling to the skin will occur
      using a specific tool (Dermapen).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrophic acne scar is a common problem with a challenging treatment. Platelet-rich plasma
      (PRP) is an autologous preparation of platelets in concentrated plasma that may be beneficial
      in the treatment of atrophic acne scars by promoting collagen deposition.

      Skin needling is a technique that uses a sterile micro needles to puncture the skin and
      release growth factors. The combination of skin needling and PRP could enhance the efficacy
      of both modalities.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">October 20, 2017</completion_date>
  <primary_completion_date type="Actual">June 23, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Scar Appearance</measure>
    <time_frame>Scar Appearance will be assessed at: T1; one day (wihtin 24 hours) before the application of the intervention(s); and T2: after three months of applying the intervention(s).</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients' Satisfaction</measure>
    <time_frame>This is going to be assessed six months following the application of the intervention and the active comparator</time_frame>
    <description>The assessment will be based on a questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Atrophic Acne Scars</condition>
  <arm_group>
    <arm_group_label>Platelet-Rich Plasma alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The scars will be injected with Platelet-Rich Plasma alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platelet-Rich Plasma with micro-needling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The scars will be dealt with using micro-needling as well as injecting Platelet-Rich Plasma</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet-Rich Plasma</intervention_name>
    <description>This Platelet-Rich Plasma will be taken from each patient and is going to be used in the treatment of atrophic acne scars</description>
    <arm_group_label>Platelet-Rich Plasma alone</arm_group_label>
    <arm_group_label>Platelet-Rich Plasma with micro-needling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Micro-needling</intervention_name>
    <description>Micro-needling will be applied on the acne scars in one side of the face.</description>
    <arm_group_label>Platelet-Rich Plasma with micro-needling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Atrophic acne scars on both sides of the face

        Exclusion Criteria:

          -  patients with active acne, herpes labialis, or bacterial infection; warts on the face,
             actinic keratosis, or skin cancer

          -  systemic retinoids intake in the previous 6 months,

          -  diabetes, pregnancy, history of keloidal scarring; or patients with severe systemic
             illness or malignancy

          -  patients on anticoagulant therapy or aspirin or have a coagulation issue,

          -  patients with hemoglobin less than 10g\dl or platelet less than 105 micron\l

          -  any previous procedures for acne scar within the last 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faiez Al-Deghlaoui, MD MSc PhD</last_name>
    <role>Study Director</role>
    <affiliation>Associate Professor of Dermatology and Veneology, Medical School, University of Damascus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Dermatology and Venereology</name>
      <address>
        <city>Damascus</city>
        <zip>DM20AM18</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <reference>
    <citation>Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994 Jul;19(4):303-8.</citation>
    <PMID>7955470</PMID>
  </reference>
  <reference>
    <citation>Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979 Apr 28;1(6171):1109-10.</citation>
    <PMID>156054</PMID>
  </reference>
  <reference>
    <citation>Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999 Oct;41(4):577-80.</citation>
    <PMID>10495379</PMID>
  </reference>
  <reference>
    <citation>Sunitha Raja V, Munirathnam Naidu E. Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian J Dent Res. 2008 Jan-Mar;19(1):42-6. Review.</citation>
    <PMID>18245923</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2016</study_first_posted>
  <last_update_submitted>December 31, 2017</last_update_submitted>
  <last_update_submitted_qc>December 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

